
La coccidioïdomycose est une mycose endémique résultant de l’inhalation d’arthrospores présentes dans les sols désertiques. Nous rapportons un cas de coccidioïdomycose pulmonaire non compliquée, chez une femme non immunodéprimée après un voyage en Californie. La présentation clinique initiale avait conduit à un diagnostic de pneumopathie communautaire, puis de tuberculose. Le diagnostic a été corrigé grâce à la sérologie et la culture du lavage bronchoalvéolaire, complétée par l’identification moléculaire de Coccidioides immitis. L’évolution était favorable après trois mois de traitement par posaconazole. La coccidioïdomycose est surtout responsable de pneumonies isolées. Le diagnostic nécessite une recherche spécifique et bénéficie de la biologie moléculaire pour l’identification d’espèce. Les facteurs associés, essentiellement immunitaires, expliquent la gravité de l’infection et la survenue de complications et rechutes à distance même en cas de traitement bien conduit. Celui-ci repose sur les antifongiques azolés ou polyéniques, plusieurs mois, voire à vie en cas d’atteinte neurologique et/ou déficit immunitaire.
Coccidioidomycosis is an endemic mycosis in the southwest of United States resulting from the inhalation of arthrospores present in desert soil. The authors present a case of uncomplicated pulmonary coccidioidomycosis in a healthy woman, acquired during a recent trip to California. The initial clinical presentation first suggested a diagnosis of community-acquired pneumonia, then of tuberculosis. The diagnosis was finally reached with blood tests and mycological culture of broncho-alveolar lavage fluid. The final identification of Coccidioides immitis was made by molecular analysis. Clinical resolution of the infection was obtained after three months of posaconazole treatment. Coccidioidomycosis is a major cause of pneumonia. Its diagnosis requires specific investigation such as mycological culture, histology, blood tests and molecular biology helps to identify the species. The progression of the disease as well as the associated immunocellular deficit are strictly correlated with the onset of complications and late relapses despite an adequate initial treatment using antifungal molecules and/or surgery.
Coccidioïdomycose, Travel, Antifungal Agents, Coccidioidomycosis, Coccidioides, Pulmonary mycosis, Middle Aged, [SDV] Life Sciences [q-bio], Diagnosis, Differential, Immunodépression, Mycose pulmonaire, Humans, Female, Antifungal treatment, France, Immunodepression, Traitement antifongique, Bronchoalveolar Lavage Fluid
Coccidioïdomycose, Travel, Antifungal Agents, Coccidioidomycosis, Coccidioides, Pulmonary mycosis, Middle Aged, [SDV] Life Sciences [q-bio], Diagnosis, Differential, Immunodépression, Mycose pulmonaire, Humans, Female, Antifungal treatment, France, Immunodepression, Traitement antifongique, Bronchoalveolar Lavage Fluid
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 20 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
